rts logo

Check out this: Vir Biotechnology Inc (VIR) could be on the verge of a big rally

Vir Biotechnology Inc (NASDAQ: VIR) is 11.43% higher on its value in year-to-date trading and has touched a low of $7.61 and a high of $27.48 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The VIR stock was last observed hovering at around $11.23 in the last trading session, with the day’s loss setting it -0.02%.

Currently trading at $11.21, the stock is 6.76% and 16.68% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.13 million and changing -0.18% at the moment leaves the stock 14.29% off its SMA200. VIR registered -56.68% loss for a year compared to 6-month loss of 16.89%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The stock witnessed a 17.26% gain in the last 1 month and extending the period to 3 months gives it a -1.67%, and is 5.46% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.90% over the week and 5.97% over the month.

Vir Biotechnology Inc (VIR) has around 587 employees, a market worth around $1.53B and $79.60M in sales. Profit margin for the company is -677.69%. Distance from 52-week low is 47.31% and -59.21% from its 52-week high. The company has generated returns on investments over the last 12 months (-32.56%).

with sales reaching $7.5M over the same period.The EPS is expected to grow by 24.16% this year, but quarterly earnings will post -6.60% year-over-year. Quarterly sales are estimated to grow 97.50% in year-over-year returns.

Vir Biotechnology Inc (VIR) Top Institutional Holders

The shares outstanding are 134.78M, and float is at 88.77M with Short Float at 7.00%.

Vir Biotechnology Inc (VIR) Insider Activity

The most recent transaction is an insider sale by De Backer Marianne,the company’sChief Executive Officer. SEC filings show that De Backer Marianne sold 72,995 shares of the company’s common stock on Apr 03 ’24 at a price of $9.46 per share for a total of $0.69 million. Following the sale, the insider now owns 0.68 million shares.

Vir Biotechnology Inc disclosed in a document filed with the SEC on Apr 01 ’24 that HANLY ANN M. (EVP & Chief Technology Officer) sold a total of 2,711 shares of the company’s common stock. The trade occurred on Apr 01 ’24 and was made at $10.05 per share for $27251.0. Following the transaction, the insider now directly holds 0.13 million shares of the VIR stock.

Still, SEC filings show that on Mar 27 ’24, Lee Sung (EVP & Chief Financial Officer) disposed off 6,008 shares at an average price of $9.89 for $59404.0. The insider now directly holds 100,492 shares of Vir Biotechnology Inc (VIR).

Related Posts